drugset / Trial / NCT00763958
Relapse Prevention to Reduce HIV Among Women Prisoners
Phase 4
Completed
44 enrolled
University of Alabama at Birmingham
National Institute on Drug Abuse (NIDA) · collab
RandomizedSingle-groupDouble-blindTreatment
Summary
This study is a feasibility and acceptability study assessing whether providing buprenorphine for women under criminal justice supervision leaving a controlled environment and returning to the community would prevent opioid relapse and reduce HIV risk behaviors.
Timeline
- Start
- 2008-05
- Primary completion
- 2009-09
- Completion
- 2010-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Buprenorphine | Other / unclassified | 32 mg | Other |